Patents Assigned to Jiangsu Yayo Biotechnology Co., Ltd.
  • Publication number: 20250101040
    Abstract: The present invention relates to a new type pyrazolopyrimidine compound, a composition thereof, a preparation method therefor and the use thereof as an anti-cancer drug having anti-tumor activity. The new type pyrazolopyrimidine compound has structural general formula (I) as shown below, is used as an ATR inhibitor, has a good tumor inhibition activity, high selectivity, good water solubility and low toxicity, and can be used for oral administration or intravenous injection administration.
    Type: Application
    Filed: December 30, 2022
    Publication date: March 27, 2025
    Applicant: Jiangsu Yayo Biotechnology Co., Ltd.
    Inventors: Fei Xiao, Yali Weng, Meng Wu